2024年11月8日,生物科技公司Avidity Biosciences, Inc.(RNA)股价在当天盘中出现大跌,跌幅达5.48%。
公司此前公布的本季度业绩报告显示,公司本季度每股亏损65美分,同比虽有所减少,但高于分析师的预期每股亏损71美分。公司本季度实现收入234万美元,同比下降17.1%,也低于市场预期。
分析人士指出,Avidity Biosciences的业绩未能达到预期是导致该股在盘中出现大跌的主要原因。虽然公司在亏损幅度和收入等方面同比有所改善,但与市场预期仍存在差距,短期内对股价形成压力。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.